The metaverse: a new source of problems for industrial property rights | El Confidencial

The protocol, agreed jointly by the Courts of Barcelona and Alicante, provides for priority handling of applications for pre-trial examination and fact-finding orders, as well as applications for interim measures —with or without a hearing— in matters relating to patents and technological innovations, industrial designs, trademarks and copyright, as well as antitrust, unfair competition and unlawful advertising, when linked to products or presentation, display, promotion, offering or sale activities connected to MWC 2026.

The newsletter covers the main developments in Pharma & Healthcare legislation and case law.

An interesting ruling has recently been handed down in relation to a case in which a domain name holder turned to the courts after losing in the ICANN (Internet Corporation for Assigned Names and Numbers) procedure, specifically Supreme Court (Civil Division) Judgment no. 1341/2025 of 30 September (ECLI:ES:TS:2025:4206).

The newsletter covers the main developments in Pharma & Healthcare legislation and case law.

The Decision of the Hamburg Local Division of the Court of First Instance of the Unified Patent Court dated 14 August 2025 grants interim relief because it claims jurisdiction to hear the substance of the matter (both the infringement of the unitary patent in the States party to the UPC Agreement and the Spanish validation of the European patent on which the unitary patent is based). To this end, the court offers a series of observations on its international jurisdiction, not all of which are accurate.

There is no doubt that the registered name of a plant variety may be used by anyone who markets plant material of that variety. However, in this specific case, the Supreme Court's statement that “the term ‘Persimmon’ was used by the defendant to identify a specific variety of caqui” is noteworthy.

In its judgment of 19 June 2025 (European Commission v Republic of Poland, C‑200/24, ECLI:EU:C:2025:459), the Court of Justice has held that the introduction by national legislation of a total prohibition on advertising for pharmacies infringes European Union law.

The judgment of the Regional High Court (Oberlandesgericht) of Cologne of 23 May 2025 (15 UKl 2/25), in which the German court rejects the application for interim relief prohibiting the defendant from processing personal data published by consumers on Facebook and Instagram for the development and improvement of artificial intelligence systems, is analysed.

The newsletter covers the main developments in Pharma & Healthcare legislation and case law.